- Lobbying
- PETER AND NORMAN
Lobbying Arrangements Results for 'Peter Norman'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Payment issues relating to orthopedic practices that own in-office ancillary services; Bundled Payments for Care Improvement Advanced Model; Issues related to Physician Self-Referral Laws (Stark la... |
The OrthoForum
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details New York and New England energy infrastructure, including electric transmission projects, power plant upgrades, the Cape Wind project (MA), and the Deepwater Wind project (RI); New York and New Eng... |
National Grid USA
|
Dow Lohnes Government Strategies LLC | |||
Details Legislation related to the promotion and regulation of natural gas development, including the potential Wyden bill and related legislation.Implementation of EPA rulemakings (current and proposed) a... |
Tenaska, Inc.
|
Dow Lohnes Government Strategies LLC | |||
Details Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; Inflation Reduction Act of 2022 implementation Medicaid Drug Rebate Program proposed rule ... |
Alkermes, Inc.
|
in-house lobbying | |||
Details Economic development efforts Port issue related to McCarran airport Brand USA HR 748 CARES Act - Issues related to C... |
Las Vegas Convention and Visitors Authority
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws ... |
National Cannabis Roundtable
|
Squire Patton Boggs | |||
Details Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues |
LifePoint Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Pati... |
Novo Nordisk Inc.
|
in-house lobbying | |||
Details Had several conversations with PA House and Senate Members on the 2023 Farm Bill. Discussed need to be passed on time, supporting a one-year extension, Farm Bureau priorities (AFBF, PFB, and Northe... |
PENNSYLVANIA FARM BUREAU
|
in-house lobbying | |||
Details Antibiotic Use in Livestock ---H.R.4012: To repeal the guidance titled "CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntar... |
Biotechnology Innovation Organization
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 6131, Commercial Space Act of 2023 Draft legislation regarding Department of Commerce Office of Space Commerce missi... |
Chamber of Commerce of the U.S.A.
|
in-house lobbying |